BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2832476)

  • 1. Identification of platelet-activating factor receptors in P388D1 murine macrophages.
    Valone FH
    J Immunol; 1988 Apr; 140(7):2389-94. PubMed ID: 2832476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of functional platelet-activating factor receptors in Raji lymphoblasts.
    Travers JB; Li Q; Kniss DA; Fertel RH
    J Immunol; 1989 Dec; 143(11):3708-13. PubMed ID: 2555416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC; Seldon PM; Barnes PJ; Giembycz MA
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L; Floch A; Mondot S; Cavero I
    Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of platelet-activating factor receptors on canine T lymphocytes.
    Mangino MJ; Murphy MK; Weiss A; Anderson CB
    J Immunol; 1993 Nov; 151(10):5310-8. PubMed ID: 8228226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
    Hwang SB; Lam MH; Hsu AH
    Mol Pharmacol; 1989 Jan; 35(1):48-58. PubMed ID: 2536468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAF binding to a single receptor in corneal epithelium plasma membrane.
    Hurst J; Ma X; Bazan HE
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):790-5. PubMed ID: 10067986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor binding to human platelet membranes.
    Valone FH; Ruis NM
    Biotechnol Appl Biochem; 1986 Oct; 8(5):465-70. PubMed ID: 3021183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors.
    Dubois C; Bissonnette E; Rola-Pleszczynski M
    J Immunol; 1989 Aug; 143(3):964-70. PubMed ID: 2545780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes.
    Marquis O; Robaut C; Cavero I
    J Pharmacol Exp Ther; 1988 Feb; 244(2):709-15. PubMed ID: 2831350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin-sensitive adenylate cyclase of a murine macrophage-like cell line (P388D1): II. Isolation and partial characterization of PGE2-binding proteins.
    Fernandez-Botran R; Suzuki T
    J Immunol; 1984 Nov; 133(5):2662-7. PubMed ID: 6090536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the presence of specific high affinity cytosolic binding sites for platelet-activating factor in human neutrophils.
    Svetlov S; Nigam S
    Biochem Biophys Res Commun; 1993 Jan; 190(1):162-6. PubMed ID: 8380690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
    Chen J; Giri SN
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
    Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
    J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of platelet-activating factor (PAF) receptor in the rat brain.
    Bito H; Kudo Y; Shimizu T
    J Lipid Mediat; 1993; 6(1-3):169-74. PubMed ID: 8395241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of platelet-activating factor-induced signal transduction in macrophages by n-3 fatty acids.
    Chakrabarti R; Hubbard NE; Lim D; Erickson KL
    Cell Immunol; 1997 Jan; 175(1):76-84. PubMed ID: 9015191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of PAF receptor and novel antagonists.
    Shen TY; Hussaini I
    Int J Tissue React; 1990; 12(2):63-9. PubMed ID: 2170286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-dependent internalization of platelet-activating factor.
    Gerard NP; Gerard C
    J Immunol; 1994 Jan; 152(2):793-800. PubMed ID: 8283052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of paf-acether receptor expression in human B cells.
    Nguer CM; Pellegrini O; Galanaud P; Benveniste J; Thomas Y; Richard Y
    J Immunol; 1992 Oct; 149(8):2742-8. PubMed ID: 1328384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages.
    Camussi G; Montrucchio G; Lupia E; Soldi R; Comoglio PM; Bussolino F
    J Immunol; 1997 Feb; 158(3):1302-9. PubMed ID: 9013973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.